274 related articles for article (PubMed ID: 12707361)
1. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.
Wunder A; Müller-Ladner U; Stelzer EH; Funk J; Neumann E; Stehle G; Pap T; Sinn H; Gay S; Fiehn C
J Immunol; 2003 May; 170(9):4793-801. PubMed ID: 12707361
[TBL] [Abstract][Full Text] [Related]
2. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
Fiehn C; Müller-Ladner U; Gay S; Krienke S; Freudenberg-Konrad S; Funk J; Ho AD; Sinn H; Wunder A
Rheumatology (Oxford); 2004 Sep; 43(9):1097-105. PubMed ID: 15199219
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate transport mechanisms: the basis for targeted drug delivery and ß-folate-receptor-specific treatment.
Fiehn C
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S40-5. PubMed ID: 21044432
[TBL] [Abstract][Full Text] [Related]
4. Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.
Liu L; Hu F; Wang H; Wu X; Eltahan AS; Stanford S; Bottini N; Xiao H; Bottini M; Guo W; Liang XJ
ACS Nano; 2019 May; 13(5):5036-5048. PubMed ID: 30978282
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo.
Fiehn C; Neumann E; Wunder A; Krienke S; Gay S; Müller-Ladner U
Ann Rheum Dis; 2004 Jul; 63(7):884-6. PubMed ID: 15194591
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment.
Zheng X; Yang H; Zhang Z; Liang X; Liu Y; Wang C; Yang X; Tang J; Mao J; Nie Y; Zhou X; Li C
Acta Biomater; 2024 Apr; 179():256-271. PubMed ID: 38484831
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Rheumatoid Arthritis by Serum Albumin Nanoparticles Coated with Mannose to Target Neutrophils.
Lyu J; Wang L; Bai X; Du X; Wei J; Wang J; Lin Y; Chen Z; Liu Z; Wu J; Zhong Z
ACS Appl Mater Interfaces; 2021 Jan; 13(1):266-276. PubMed ID: 33379867
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts.
Suzuki K; Yoshida K; Ueha T; Kaneshiro K; Nakai A; Hashimoto N; Uchida K; Hashimoto T; Kawasaki Y; Shibanuma N; Nakagawa N; Sakai Y; Hashiramoto A
Arthritis Res Ther; 2018 Mar; 20(1):55. PubMed ID: 29566767
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
[TBL] [Abstract][Full Text] [Related]
10. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery.
Lee SW; Kim JH; Park MC; Park YB; Chae WJ; Morio T; Lee DH; Yang SH; Lee SK; Lee SK; Lee SK
Biomaterials; 2012 Feb; 33(5):1563-72. PubMed ID: 22098778
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
[TBL] [Abstract][Full Text] [Related]
12. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.
Li YB; Xu P; Xu K; Cai YS; Sun MY; Yang L; Sun J; Lu SM
Mol Cell Biochem; 2016 Sep; 420(1-2):161-70. PubMed ID: 27522665
[TBL] [Abstract][Full Text] [Related]
14. A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis.
Shin JM; Kim SH; Thambi T; You DG; Jeon J; Lee JO; Chung BY; Jo DG; Park JH
Chem Commun (Camb); 2014 Jul; 50(57):7632-5. PubMed ID: 24893961
[TBL] [Abstract][Full Text] [Related]
15. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis.
Fiehn C; Kratz F; Sass G; Müller-Ladner U; Neumann E
Ann Rheum Dis; 2008 Aug; 67(8):1188-91. PubMed ID: 18408252
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
Nakazawa F; Matsuno H; Yudoh K; Katayama R; Sawai T; Uzuki M; Kimura T
J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
[TBL] [Abstract][Full Text] [Related]
17. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
[TBL] [Abstract][Full Text] [Related]
18. Native albumin for targeted drug delivery.
Neumann E; Frei E; Funk D; Becker MD; Schrenk HH; Müller-Ladner U; Fiehn C
Expert Opin Drug Deliv; 2010 Aug; 7(8):915-25. PubMed ID: 20586704
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance.
Kim HY; Lee SW; Park SY; Baek SH; Lee CW; Hong KW; Kim CD
Life Sci; 2012 Sep; 91(7-8):250-7. PubMed ID: 22820172
[TBL] [Abstract][Full Text] [Related]
20. Combinational strategy using albumin-based nanoparticles to enable synergetic anti-rheumatic efficacy and reduced hepatotoxicity.
Li J; Zhang X; Pan L; Lin X; Zhang B; Ren J; Wang Q
Int J Pharm; 2024 May; 656():124111. PubMed ID: 38609057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
